Literature DB >> 11245602

Potent NK1 antagonism by SR-140333 reduces rat colonic secretory response to immunocyte activation.

D Moriarty1, N Selve, A W Baird, J Goldhill.   

Abstract

The potent neurokinin receptor 1 (NK1) antagonist SR-140333 has previously been shown to reduce castor oil-induced secretion in animal models. The importance of tachykinins in neuroimmune control of secretion and the effect of SR-140333 on key points in this pathway were elucidated in the present study to determine the type of intestinal dysfunction best targeted by this antagonist. Rat colonic secretion and substance P (SP) release were determined in vitro with the use of Ussing chamber and enzyme immunoassay techniques. NK1 receptors played a secretory role as receptor agonists stimulated secretion and SR-140333 antagonized the response to SP response (pK(b) = 9.2). Sensory fiber stimulation released SP and evoked a large secretion that was reduced by 69% in the presence of SR-140333 (10 nM). Likewise, mastocytes also released SP. The subsequent secretory response was reduced by 43% in the presence of SR-140333 (50 nM). SP was also released from granulocytes; however, this did not cause secretion. Functional NK3 receptors were present in the colon as senktide stimulated secretion, an effect that was increased during stress. We conclude that NK3 receptors may play a role in stress-related disorders, whereas NK1 receptors are more important in mast cell/afferent-mediated secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245602     DOI: 10.1152/ajpcell.2001.280.4.C852

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  8 in total

1.  Regional variations in neurokinin receptor subtype contributions to muscularis mucosae and epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; William H Percy
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

Review 2.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

Review 3.  Irritable bowel syndrome: recent and novel therapeutic approaches.

Authors:  Viola Andresen; Michael Camilleri
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Current and novel therapeutic options for irritable bowel syndrome management.

Authors:  M Camilleri; V Andresen
Journal:  Dig Liver Dis       Date:  2009-08-08       Impact factor: 4.088

5.  Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon.

Authors:  Caroline B Appleyard; Marangelie Morales; Cariluz Santiago
Journal:  Dig Dis Sci       Date:  2007-05-18       Impact factor: 3.199

Review 6.  Peripheral mechanisms of dental pain: the role of substance P.

Authors:  Paola Sacerdote; Luca Levrini
Journal:  Mediators Inflamm       Date:  2012-02-09       Impact factor: 4.711

7.  Communication Between Enteric Neurons, Glia, and Nociceptors Underlies the Effects of Tachykinins on Neuroinflammation.

Authors:  Ninotchska M Delvalle; Christine Dharshika; Wilmarie Morales-Soto; David E Fried; Lukas Gaudette; Brian D Gulbransen
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-05-29

8.  Translational research of temporomandibular joint pathology: a preliminary biomarker and fMRI study.

Authors:  Andre Barkhordarian; Gary Demerjian; Francesco Chiappelli
Journal:  J Transl Med       Date:  2020-01-13       Impact factor: 8.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.